|
|
|
Insider
Information: |
Stenhouse Mark |
Relationship: |
|
City: |
Madison |
State: |
WI |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
49,071 |
|
Indirect Shares
|
355 |
|
|
Direct
Value |
$2,083,573 |
|
|
Indirect Value
|
$25,013 |
|
|
Total
Shares |
49,426 |
|
|
Total
Value |
$2,108,586 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Exact Sciences Corp |
EXAS |
President, Cologuard |
2020-04-03 |
29,571 |
2020-04-03 |
355 |
Premium* |
|
Prometheus Biosciences, Inc. |
RXDX |
Chief Operating Officer |
2023-06-16 |
0 |
2023-06-16 |
0 |
Premium* |
|
Phathom Pharmaceuticals, Inc. |
PHAT |
|
2024-05-23 |
19,500 |
2023-05-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EXAS |
Exact Sciences Corp |
President, Cologuard |
|
2019-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,500 |
0 |
- |
|
EXAS |
Exact Sciences Corp |
President, Cologuard |
|
2019-04-03 |
4 |
AS |
$92.54 |
$1,035,696 |
D/D |
(11,192) |
14,308 |
0 |
- |
|
EXAS |
Exact Sciences Corp |
President, Cologuard |
|
2020-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,262 |
17,570 |
0 |
- |
|
EXAS |
Exact Sciences Corp |
President, Cologuard |
|
2020-02-27 |
4 |
AS |
$80.27 |
$84,364 |
D/D |
(1,051) |
16,519 |
0 |
- |
|
EXAS |
Exact Sciences Corp |
President, Cologuard |
|
2020-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
41,519 |
0 |
- |
|
EXAS |
Exact Sciences Corp |
President, Cologuard |
|
2020-04-03 |
4 |
AS |
$56.69 |
$677,332 |
D/D |
(11,948) |
29,571 |
0 |
- |
|
RXDX |
Prometheus Biosciences, I... |
Chief Operating Officer |
|
2021-03-16 |
4 |
B |
$19.00 |
$266,000 |
D/D |
14,000 |
14,000 |
2.74 |
- |
|
RXDX |
Prometheus Biosciences, I... |
Chief Operating Officer |
|
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
9,811 |
26,442 |
0 |
- |
|
PHAT |
Phathom Pharmaceuticals, ... |
Director |
|
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
0 |
- |
|
RXDX |
Prometheus Biosciences, I... |
Chief Operating Officer |
|
2023-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,000) |
12,708 |
0 |
- |
|
RXDX |
Prometheus Biosciences, I... |
Chief Operating Officer |
|
2023-06-01 |
4 |
A |
$0.00 |
$0 |
I/I |
14,000 |
14,000 |
0 |
- |
|
RXDX |
Prometheus Biosciences, I... |
Chief Operating Officer |
|
2023-06-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,754) |
0 |
0 |
- |
|
RXDX |
Prometheus Biosciences, I... |
Chief Operating Officer |
|
2023-06-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(14,000) |
0 |
0 |
- |
|
PHAT |
Phathom Pharmaceuticals, ... |
|
|
2024-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10,500 |
19,500 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|